Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study to Assess Bacterial Count Reduction of Three Octenidine Mouthwash Concentrations in Comparison to a Placebo in Patients With Mild Gingivitis

NCT02138552 is registered in ClinicalTrials.gov with Schülke & Mayr GmbH as lead sponsor.

NCT NCT02138552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02138552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study to Assess Bacterial Count Reduction of Three Octenidine Mouthwash Concentrations in Comparison to a Placebo in Patients With Mild Gingivitis
Lead sponsor
Schülke & Mayr GmbH
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2013
Completion date
April 30, 2014
Enrollment
90 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gingivitis